Mercator Medical S.A. (WSE: MRC)

Mercator Medical Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	224.29	217.33	223.34	339.61	399.84	14.78
Short-Term Investments	-	109.53	198.46	195.7	147.32	-
Cash & Short-Term Investments	224.29	326.86	421.8	535.3	547.16	14.78
Cash Growth	-45.46%	-22.51%	-21.20%	-2.17%	3601.26%	-8.78%
Accounts Receivable	99.15	61.17	49.97	99.27	97.13	74.02
Other Receivables	6.73	42.51	19.54	25.32	19.28	6.1
Receivables	106.31	104.11	69.92	124.6	116.42	80.12
Inventory	121.58	153.09	204.67	253.36	429.6	89.42
Prepaid Expenses	-	0.52	0.45	0.56	0.43	0.29
Other Current Assets	138.05	0.66	0.72	0.35	1.92	6.45
Total Current Assets	590.23	585.24	697.56	914.17	1,096	191.06
Property, Plant & Equipment	233.72	251.66	281.96	334.65	183.41	189.31
Long-Term Investments	-	2.01	0.73	-	-	-
Other Intangible Assets	32.52	33.14	24.11	9.65	3.87	3.77
Long-Term Deferred Tax Assets	22.55	24.16	29.7	28.38	6.49	2.54
Other Long-Term Assets	82.14	2.96	4.05	1.68	0.02	0.03
Total Assets	961.16	965.23	1,083	1,289	1,289	386.71
Accounts Payable	74.11	53.49	35.8	62.41	100.58	89.05
Accrued Expenses	-	9.61	12.85	16.03	22.81	7.3
Short-Term Debt	0.11	0.15	0.21	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	0.69	49.57
Current Portion of Leases	0.96	0.85	0.72	1.31	1.54	1.21
Current Income Taxes Payable	2.1	4.24	0.03	24.61	89.42	1.03
Current Unearned Revenue	-	0.63	3.1	27.72	23.56	1.35
Other Current Liabilities	6.94	9.51	7.25	0.97	1.31	3.14
Total Current Liabilities	84.21	78.47	59.96	133.05	239.89	152.65
Long-Term Debt	-	-	-	-	-	95.89
Long-Term Leases	4.04	4.41	2.46	3.52	2.02	1.59
Long-Term Unearned Revenue	-	0.15	0.16	0.16	0.17	0.18
Long-Term Deferred Tax Liabilities	25.56	20.87	8.54	4.35	2.96	1.07
Other Long-Term Liabilities	1.81	1.61	2.73	2.23	1.13	0.86
Total Liabilities	115.63	105.52	73.85	143.32	246.17	252.25
Common Stock	9.77	10.65	10.65	10.65	10.6	10.59
Additional Paid-In Capital	30.74	30.74	57.84	57.84	57.14	58.79
Retained Earnings	868.53	854.82	888.22	1,079	963.76	47.53
Comprensive Income & Other	-60.71	-34.12	52.02	-3.28	8.45	16.22
Total Common Equity	848.33	862.09	1,009	1,144	1,040	133.13
Minority Interest	-2.8	-2.38	0.49	1.36	3.18	1.33
Shareholders' Equity	845.53	859.71	1,009	1,145	1,043	134.46
Total Liabilities & Equity	961.16	965.23	1,083	1,289	1,289	386.71
Total Debt	5.11	5.41	3.39	4.83	4.25	148.27
Net Cash (Debt)	219.18	321.45	418.41	530.47	542.91	-133.49
Net Cash Growth	-45.95%	-23.17%	-21.12%	-2.29%	-	-
Net Cash Per Share	21.30	33.54	42.82	52.41	51.56	-12.61
Filing Date Shares Outstanding	10.48	9.77	10.65	10.65	10.41	10.59
Total Common Shares Outstanding	10.48	9.42	10.65	10.65	10.41	10.59
Working Capital	506.02	506.76	637.6	781.12	855.63	38.41
Book Value Per Share	80.95	91.54	94.74	107.43	99.92	12.57
Tangible Book Value	815.81	828.95	984.62	1,134	1,036	129.35
Tangible Book Value Per Share	77.84	88.02	92.48	106.53	99.55	12.22
Land	-	41.8	47.24	51.94	8.78	8.89
Buildings	-	95.68	110.96	79.99	74.45	74.29
Machinery	-	221.5	201.74	172.21	170.27	164.13
Construction In Progress	-	1.07	32.75	115.12	4.88	4.23

Source: S&P Capital IQ. Standard template. Financial Sources.